Thorac Cardiovasc Surg 2002; 50(1): 55-58
DOI: 10.1055/s-2002-20166
Original Thoracic
Original Paper
© Georg Thieme Verlag Stuttgart · New York

Prognostic Factors and c-erbB-2 Expression in
Non-Small-Cell Lung Carcinoma
(c-erbB-2 in Non-Small Cell Lung Carcinoma)

K.  Bakır1 , R.  Uçak1 , B.  Tunçözgür2 , L.  Elbeyli2
  • 1Department of Pathology
  • 2Department of Cardio-thoracic Surgery, Medical faculty of Gaziantep University, Turkey
Further Information

Publication History

April 2, 2001

Publication Date:
15 February 2002 (online)

Preview

Abstract

The human proto-oncogene c-erbB-2/neu gene, which is structurally similar to the epidermal growth factor receptor gene, encodes a transmembrane protein of 185 kDa (p185) with tyrosine kinase activity. Paraffin-embedded sections from 42 cases with lung carcinoma were stained immunohistochemically using the Avidin-Biotin Horseradish Peroxidase method to search for c-erbB-2 reaction. Results were evaluated semiquantitatively. The c-erbB-2 expression from each case was compared according to tumor type, grade, mitotic activity, clinical stage and lymph node metastasis. Results were statistically analyzed by using chi-square tests. We were unable to detect a significant relation between c-erbB-2 expression and histological grade, nodal metastasis, number of mitotic figures or tumor type, but we did observe a statistically significant correlation between clinical stage and increased c-erbB-2 expression (p < 0.05). In our opinion, c-erbB-2 expression in human lung carcinomas may be useful for determining clinical outcome.

References

Kemal Bakır

Medical Faculty of Gaziantep University
Pathology Department

Gaziantep

Turkey

Phone: +90 (342) 360 39 10 (7150)

Fax: +90 (342) 336 55 05

Email: Kemalbakir@TTnet.net